These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 29908149

  • 1. A Hexokinase 2 Modulator for Field-Directed Treatment of Experimental Actinic Keratoses.
    Behar V, Pahima H, Kozminsky-Atias A, Arbel N, Loeb E, Herzberg M, Becker OM.
    J Invest Dermatol; 2018 Dec; 138(12):2635-2643. PubMed ID: 29908149
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of novel methyl jasmonate derivatives and evaluation of their biological activity in various cancer cell lines.
    Sucu BO, Ipek OS, Kurtulus SO, Yazici BE, Karakas N, Guzel M.
    Bioorg Chem; 2019 Oct; 91():103146. PubMed ID: 31377389
    [Abstract] [Full Text] [Related]

  • 3. Methyl jasmonate leads to necrosis and apoptosis in hepatocellular carcinoma cells via inhibition of glycolysis and represses tumor growth in mice.
    Li J, Chen K, Wang F, Dai W, Li S, Feng J, Wu L, Liu T, Xu S, Xia Y, Lu J, Zhou Y, Xu L, Guo C.
    Oncotarget; 2017 Jul 11; 8(28):45965-45980. PubMed ID: 28498814
    [Abstract] [Full Text] [Related]

  • 4. Ingenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches.
    Cozzi SJ, Ogbourne SM, James C, Rebel HG, de Gruijl FR, Ferguson B, Gardner J, Lee TT, Larcher T, Suhrbier A.
    J Invest Dermatol; 2012 Apr 11; 132(4):1263-71. PubMed ID: 22189786
    [Abstract] [Full Text] [Related]

  • 5. Methyl jasmonate binds to and detaches mitochondria-bound hexokinase.
    Goldin N, Arzoine L, Heyfets A, Israelson A, Zaslavsky Z, Bravman T, Bronner V, Notcovich A, Shoshan-Barmatz V, Flescher E.
    Oncogene; 2008 Aug 07; 27(34):4636-43. PubMed ID: 18408762
    [Abstract] [Full Text] [Related]

  • 6. Disruption of the hexokinase-VDAC complex for tumor therapy.
    Galluzzi L, Kepp O, Tajeddine N, Kroemer G.
    Oncogene; 2008 Aug 07; 27(34):4633-5. PubMed ID: 18469866
    [Abstract] [Full Text] [Related]

  • 7. Methyl jasmonate: a plant stress hormone as an anti-cancer drug.
    Cohen S, Flescher E.
    Phytochemistry; 2009 Sep 07; 70(13-14):1600-9. PubMed ID: 19660769
    [Abstract] [Full Text] [Related]

  • 8. Topical AC-11 abates actinic keratoses and early squamous cell cancers in hairless mice exposed to Ultraviolet A (UVA) radiation.
    Mentor JM, Etemadi A, Patta AM, Scheinfeld N.
    Dermatol Online J; 2015 Apr 16; 21(4):. PubMed ID: 25933088
    [Abstract] [Full Text] [Related]

  • 9. Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer.
    Erlendsson AM.
    Dan Med J; 2017 Nov 16; 64(11):. PubMed ID: 29115209
    [Abstract] [Full Text] [Related]

  • 10. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V, Ben-Hail D, Admoni L, Krelin Y, Tripathi SS.
    Biochim Biophys Acta; 2015 Oct 16; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [Abstract] [Full Text] [Related]

  • 11. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase.
    Shoshan-Barmatz V, Zakar M, Rosenthal K, Abu-Hamad S.
    Biochim Biophys Acta; 2009 May 16; 1787(5):421-30. PubMed ID: 19094960
    [Abstract] [Full Text] [Related]

  • 12. Effect of methyl jasmonate and 3-bromopyruvate combination therapy on mice bearing the 4 T1 breast cancer cell line.
    Yousefi S, Darvishi P, Yousefi Z, Pourfathollah AA.
    J Bioenerg Biomembr; 2020 Apr 16; 52(2):103-111. PubMed ID: 31960257
    [Abstract] [Full Text] [Related]

  • 13. Topical therapies for skin cancer and actinic keratosis.
    Haque T, Rahman KM, Thurston DE, Hadgraft J, Lane ME.
    Eur J Pharm Sci; 2015 Sep 18; 77():279-89. PubMed ID: 26091570
    [Abstract] [Full Text] [Related]

  • 14. Induction of cancer, actinic keratosis, and specific p53 mutations by UVB light in human skin maintained in severe combined immunodeficient mice.
    Nomura T, Nakajima H, Hongyo T, Taniguchi E, Fukuda K, Li LY, Kurooka M, Sutoh K, Hande PM, Kawaguchi T, Ueda M, Takatera H.
    Cancer Res; 1997 Jun 01; 57(11):2081-4. PubMed ID: 9187098
    [Abstract] [Full Text] [Related]

  • 15. In silico construction of HK2-VDAC1 complex and investigating the HK2 binding-induced molecular gating mechanism of VDAC1.
    Zhang D, Yip YM, Li L.
    Mitochondrion; 2016 Sep 01; 30():222-8. PubMed ID: 27544294
    [Abstract] [Full Text] [Related]

  • 16. Mild Alkalization Acutely Triggers the Warburg Effect by Enhancing Hexokinase Activity via Voltage-Dependent Anion Channel Binding.
    Quach CH, Jung KH, Lee JH, Park JW, Moon SH, Cho YS, Choe YS, Lee KH.
    PLoS One; 2016 Sep 01; 11(8):e0159529. PubMed ID: 27479079
    [Abstract] [Full Text] [Related]

  • 17. SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis.
    Shangguan X, He J, Ma Z, Zhang W, Ji Y, Shen K, Yue Z, Li W, Xin Z, Zheng Q, Cao Y, Pan J, Dong B, Cheng J, Wang Q, Xue W.
    Nat Commun; 2021 Mar 22; 12(1):1812. PubMed ID: 33753739
    [Abstract] [Full Text] [Related]

  • 18. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B.
    N Engl J Med; 2012 Mar 15; 366(11):1010-9. PubMed ID: 22417254
    [Abstract] [Full Text] [Related]

  • 19. Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels.
    Chiara F, Castellaro D, Marin O, Petronilli V, Brusilow WS, Juhaszova M, Sollott SJ, Forte M, Bernardi P, Rasola A.
    PLoS One; 2008 Mar 19; 3(3):e1852. PubMed ID: 18350175
    [Abstract] [Full Text] [Related]

  • 20. VDAC electronics: 5. Mechanism and computational model of hexokinase-dependent generation of the outer membrane potential in brain mitochondria.
    Lemeshko VV.
    Biochim Biophys Acta Biomembr; 2018 Dec 19; 1860(12):2599-2607. PubMed ID: 30291922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.